QUEBEC CITY, March 21 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. announced that it will host a live webcast of the presentations from its Analyst and Investor Day being held today beginning at 9:30 a.m. (ET). AEterna Zentaris’ management will present the Company’s strategy as a late-stage, pure play biopharmaceutical company, an update on the development of its lead compounds cetrorelix, ozarelix and perifosine, as well as other earlier-stage, promising product candidates.
The live webcast of these presentations will be available on the Company’s website at www.aeternazentaris.com in the Investors section. A replay will also be available for a period of 30 days.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is a late-stage, global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization.
News releases and additional information are available at
AETERNA ZENTARIS INC.
CONTACT: Jenene Thomas, Senior Director, Investor Relations & CorporateCommunications, (418) 655-6420, jenene.thomas@aeternazentaris.com; PaulBurroughs, Media Relations, (418) 652-8525 ext. 406,paul.burroughs@aeternazentaris.com